Petasin inhibits adipogenesis in 3T3-F442A cells (IC50 of 0.95 μM). It inhibits lipid synthesis factors ACC1, FAS, and SCD1 by targeting transcription factors PPARγ and C/EBPα, along with TRPA1 and TRPV1 channels. Petasin inhibits mitochondrial complex I, thus suppressing tumor growth and metastasis. It also activates the AMPK pathway, regulating glucose and lipid metabolism. Petasin is orally active.
- Home
- Mitochondrial Diseases & Models
- By System Involvement
- Systemic Mitochondrial Disease
- Alpers Disease
- Barth Syndrome
- Carnitine Deficiency
- Creatine Deficiency Syndromes
- Co-Enzyme Q10 Deficience
- Friedreich’s Ataxia
- Kearns-Sayre Syndrome
- Lactic Acidosis
- Leigh Syndrome
- Mitochondrial DNA Depletion Syndrome
- MELAS Syndrome
- Multiple Mitochondrial Dysfunction Syndrome
- Short-Chain Acyl-CoA Dehydrogenase Deficiency
- Thymidine Kinase 2 Deficiency
- Mitochondrial Neurogastrointestinal Encephalopathy
- Organ-specific Mitochondrial Diseases
- Systemic Mitochondrial Disease
- By Etiology
- By System Involvement
- Solutions
- Products
- Mitochondrial Isolation Reagents & Kits
- Mitochondrial Staining Reagents & Kits
- Mitochondrial Disease Diagnostic Reagents & Kits
- Biochemical Inhibitors & Activators
- Mitochondrial Specific Antibodies
- Mitochondrial Recombinant Proteins
- Mitochondria Related Peptides
- Natural Products Targeting Mitochondria
- Resource
- Company